$0.6500
-0.00329-0.50%
al cierre: -
$0.7100
0.069.23%
After hour: Sep 12, 8:00 AM EDT
Comments
Loading...
Informe de interés en corto
El interés corto en Brainstorm Cell Therapeutics Inc (OTC:BCLI) ha disminuido durante el último período de informe, aumentando en descenso desde 300.36K hasta 280.13K. Esto representa el 2.91% de las acciones disponibles públicamente de la empresa.
El interés en corto en Brainstorm Cell Corp (OOTC:BCLI) disminuyó durante el último período de informe, cayendo de 280,30 millones a 275,20 millones. Esto hizo que el 1,17 % de las acciones disponibles públicamente de la empresa se pusieran en corto.
Basado en el volumen promedio reciente de 44.47K acciones negociadas por día, tomaría 6.3 día(s) para que los poseedores de este interés corto cierren sus posiciones sin impulsar bruscamente el precio de las acciones.
Interés en corto
280.13K
Interés en corto %
2.91%
Días para cubrir
6.3
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
BCLI | Brainstorm Cell Therapeutics I | 10/15/2025 | 10/24/2025 | 2.91% | 9,618,726 | 280,130 | 44,471 | 6.3 | |
BCLI | Brainstorm Cell Therapeutics I | 09/30/2025 | 10/09/2025 | 3.12% | 9,618,726 | 300,362 | 45,421 | 6.61 | |
BCLI | Brainstorm Cell Therapeutics I | 09/15/2025 | 09/24/2025 | 3.40% | 9,618,726 | 327,152 | 39,898 | 8.2 | |
BCLI | Brainstorm Cell Therapeutics I | 08/29/2025 | 09/10/2025 | 3.56% | 9,618,726 | 342,635 | 61,190 | 5.6 | |
BCLI | Brainstorm Cell Therapeutics I | 08/15/2025 | 08/26/2025 | 3.62% | 9,618,726 | 348,234 | 156,516 | 2.22 | |
BCLI | Brainstorm Cell Therapeutics I | 07/31/2025 | 08/11/2025 | 4.75% | 9,081,476 | 431,321 | 614,484 | 1 | |
BCLI | Brainstorm Cell Therapeutics I | 07/15/2025 | 07/24/2025 | 6.24% | 9,081,476 | 566,390 | 422,865 | 1.34 | |
BCLI | Brainstorm Cell Therapeutics I | 06/30/2025 | 07/10/2025 | 6.66% | 9,081,476 | 604,460 | 449,766 | 1.34 | |
BCLI | Brainstorm Cell Therapeutics I | 06/13/2025 | 06/25/2025 | 6.45% | 7,181,493 | 463,315 | 430,860 | 1.08 | |
BCLI | Brainstorm Cell Therapeutics I | 05/30/2025 | 06/10/2025 | 7.48% | 7,181,493 | 536,937 | 6,614,599 | 1 | |
BCLI | Brainstorm Cell Therapeutics I | 05/15/2025 | 05/27/2025 | 2.92% | 7,181,493 | 209,504 | 117,744 | 1.78 | |
BCLI | Brainstorm Cell Therapeutics I | 04/30/2025 | 05/09/2025 | 5.39% | 5,405,805 | 291,418 | 157,119 | 1.85 | |
BCLI | Brainstorm Cell Therapeutics I | 04/15/2025 | 04/25/2025 | 6.41% | 5,405,805 | 346,646 | 610,656 | 1 | |
BCLI | Brainstorm Cell Therapeutics I | 03/31/2025 | 04/09/2025 | 2.54% | 5,405,805 | 137,216 | 46,715 | 2.94 | |
BCLI | Brainstorm Cell Therapeutics I | 03/14/2025 | 03/25/2025 | 2.27% | 5,405,805 | 122,765 | 16,867 | 7.28 | |
BCLI | Brainstorm Cell Therapeutics I | 02/28/2025 | 03/11/2025 | 1.98% | 5,405,805 | 107,230 | 37,546 | 2.86 | |
BCLI | Brainstorm Cell Therapeutics I | 02/14/2025 | 02/26/2025 | 2.05% | 5,405,805 | 110,846 | 32,897 | 3.37 | |
BCLI | Brainstorm Cell Therapeutics I | 01/31/2025 | 02/11/2025 | 1.69% | 5,405,805 | 91,385 | 63,905 | 1.43 | |
BCLI | Brainstorm Cell Therapeutics I | 01/15/2025 | 01/27/2025 | 3.20% | 5,405,805 | 172,989 | 57,202 | 3.02 | |
BCLI | Brainstorm Cell Therapeutics I | 12/31/2024 | 01/10/2025 | 1.73% | 5,405,805 | 93,267 | 159,130 | 1 | |
BCLI | Brainstorm Cell Therapeutics I | 12/13/2024 | 12/24/2024 | 2.82% | 5,405,805 | 152,370 | 85,033 | 1.79 | |
BCLI | Brainstorm Cell Therapeutics I | 11/29/2024 | 12/10/2024 | 2.74% | 5,405,805 | 148,229 | 99,445 | 1.49 | |
BCLI | Brainstorm Cell Therapeutics I | 11/15/2024 | 11/26/2024 | 3.22% | 5,405,805 | 173,850 | 162,693 | 1.07 | |
BCLI | Brainstorm Cell Therapeutics I | 10/31/2024 | 11/11/2024 | 2.19% | 5,017,985 | 109,802 | 87,664 | 1.25 | |
BCLI | Brainstorm Cell Therapeutics I | 10/15/2024 | 10/24/2024 | 3.31% | 5,017,985 | 165,892 | 87,883 | 1.89 | |
BCLI | Brainstorm Cell Therapeutics I | 09/30/2024 | 10/09/2024 | 37.24% | 5,017,985 | 1,868,815 | 387,661 | 4.82 | |
BCLI | Brainstorm Cell Therapeutics I | 09/13/2024 | 09/24/2024 | 1.86% | 75,269,777 | 1,399,016 | 229,978 | 6.08 | |
BCLI | Brainstorm Cell Therapeutics I | 08/30/2024 | 09/11/2024 | 1.71% | 75,269,777 | 1,286,721 | 290,915 | 4.42 | |
BCLI | Brainstorm Cell Therapeutics I | 08/15/2024 | 08/26/2024 | 2.15% | 75,269,777 | 1,617,894 | 673,587 | 2.4 | |
BCLI | Brainstorm Cell Therapeutics I | 07/31/2024 | 08/09/2024 | 1.39% | 76,836,964 | 1,065,531 | 362,829 | 2.94 | |
BCLI | Brainstorm Cell Therapeutics I | 07/15/2024 | 07/24/2024 | 1.41% | 76,836,964 | 1,080,538 | 533,231 | 2.03 | |
BCLI | Brainstorm Cell Therapeutics I | 06/28/2024 | 07/10/2024 | 2.13% | 68,918,200 | 1,468,709 | 716,077 | 2.05 | |
BCLI | Brainstorm Cell Therapeutics I | 06/14/2024 | 06/26/2024 | 1.32% | 67,335,703 | 890,588 | 793,969 | 1.12 | |
BCLI | Brainstorm Cell Therapeutics I | 05/31/2024 | 06/11/2024 | 1.67% | 67,335,703 | 1,121,353 | 497,781 | 2.25 | |
BCLI | Brainstorm Cell Therapeutics I | 05/15/2024 | 05/24/2024 | 2.10% | 67,335,703 | 1,414,121 | 805,129 | 1.76 | |
BCLI | Brainstorm Cell Therapeutics I | 04/30/2024 | 05/09/2024 | 3.20% | 65,597,037 | 2,098,310 | 570,888 | 3.68 | |
BCLI | Brainstorm Cell Therapeutics I | 04/15/2024 | 04/24/2024 | 3.04% | 65,597,037 | 1,991,679 | 1,382,034 | 1.44 | |
BCLI | Brainstorm Cell Therapeutics I | 03/28/2024 | 04/09/2024 | 2.05% | 65,597,037 | 1,343,163 | 1,894,389 | 1 | |
BCLI | Brainstorm Cell Therapeutics I | 03/15/2024 | 03/26/2024 | 1.82% | 46,641,147 | 850,265 | 518,858 | 1.64 | |
BCLI | Brainstorm Cell Therapeutics I | 02/29/2024 | 03/11/2024 | 2.29% | 46,641,147 | 1,067,002 | 804,804 | 1.33 | |
BCLI | Brainstorm Cell Therapeutics I | 02/15/2024 | 02/27/2024 | 2.65% | 46,641,147 | 1,234,664 | 795,127 | 1.55 | |
BCLI | Brainstorm Cell Therapeutics I | 01/31/2024 | 02/09/2024 | 4.36% | 46,641,147 | 2,034,743 | 796,006 | 2.56 | |
BCLI | Brainstorm Cell Therapeutics I | 01/12/2024 | 01/24/2024 | 5.12% | 46,641,147 | 2,386,380 | 1,077,964 | 2.21 | |
BCLI | Brainstorm Cell Therapeutics I | 12/29/2023 | 01/10/2024 | 9.02% | 46,641,147 | 4,209,007 | 4,318,485 | 1 | |
BCLI | Brainstorm Cell Therapeutics I | 12/15/2023 | 12/27/2023 | 7.20% | 46,641,147 | 3,357,336 | 4,893,971 | 1 | |
BCLI | Brainstorm Cell Therapeutics I | 11/30/2023 | 12/11/2023 | 7.51% | 46,641,147 | 3,500,593 | 3,994,582 | 1 | |
BCLI | Brainstorm Cell Therapeutics I | 11/15/2023 | 11/27/2023 | 8.09% | 46,641,147 | 3,772,910 | 1,035,083 | 3.65 | |
BCLI | Brainstorm Cell Therapeutics I | 10/31/2023 | 11/09/2023 | 8.43% | 42,357,533 | 3,570,310 | 1,349,681 | 2.65 |
En busca de los valores más cortos?